Castle Creek Biosciences buys gene therapy company weeks after canceling IPO plans
January 10, 2022 at 14:55 PM EST
The deal will enable the Exton company to expand both its new product pipeline and its technology platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|